COVID-19 vaccine uptake in Zimbabwe and Sierra Leone: an application of Health Belief Model constructs.

Publication date: Feb 04, 2025

While African countries, in general, experienced a milder COVID-19 impact compared to Western nations, they faced challenges with vaccine uptake. Specifically, Zimbabwe and Sierra Leone saw vaccine acceptance rates below global averages. This research delves into the underlying factors that influenced these disparities in vaccine acceptance in these two countries, using the Health Belief Model (HBM) and the Theory of Planned Behavior (TPB) as guiding frameworks. This study utilized data from a cross-sectional survey encompassing 2,312 participants from areas where the Africa Christian Health Associations Platform (ACHAP) operates in Zimbabwe and Sierra Leone. The survey assessed respondents’ views in line with core HBM and TPB constructs, in addition to their levels of vaccine acceptance. We then employed adjusted logistic regression models to investigate the correlation between health behavior change theory constructs and vaccine uptake, taking into account variables like gender, age, education, and country of residence. Several associations were identified, including high vaccine uptake correlated with a heightened perceived threat of COVID-19 (OR = 2. 674; p 

Open Access PDF

Concepts Keywords
Christian Adolescent
Models Adult
Vaccine Behavior change theory
Zimbabwe COVID-19
COVID-19 vaccine uptake
COVID-19 Vaccines
COVID-19 Vaccines
Cross-Sectional Studies
Female
Health Belief Model
Humans
Male
Middle Aged
Sierra Leone
Sierra Leone
Surveys and Questionnaires
Vaccination Hesitancy
Young Adult
Zimbabwe
Zimbabwe

Semantics

Type Source Name
disease MESH COVID-19
disease IDO country
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH infection
drug DRUGBANK Trestolone
disease MESH anxiety
drug DRUGBANK Water
disease MESH measles
pathway KEGG Measles
disease IDO history
disease IDO susceptibility
disease MESH Melas
disease MESH educational attainment
drug DRUGBANK Uridine monophosphate
disease IDO process
disease MESH morbidity
drug DRUGBANK Ademetionine

Original Article

(Visited 3 times, 1 visits today)